United States is a leader in healthcare information technology use and adoption by physicians, and the penetration of healthcare IT is nearly equal among primary physicians and specialists, finds new study by Accenture.  

A new survey found hospitals paying widely varying prices for the same implantable devices, and blamed confidentiality clauses in sales agreements for preventing buyers from getting the best deals. 

Number indicates a 17 percent increase over FY2012 budget; industry user fees will fund 98 percent of increase.

Technologies capable of facilitating changes in clinical pathways, lowering healthcare expenditure, eliminating non-essential diagnostic procedures, and enhancing accuracy of diagnostic procedures are expected to gain popularity in the medical equipment market, concludes new market research report. 

The Japanese company, known for its TVs, games and music, is making acquisitions to bolster its medical business, foraying into medical imaging business, and setting up an innovation center to scout out new business opportunities.

Company attributed the departure to “family reasons” and offered no other details; sudden departure has some questioning future growth of the company. 

The federal government details exemptions for medical device service providers and early-stage companies and addresses concerns around double taxation. 

New funding helps company further prepare to launch Hemolung , its artificial lung, in Germany this year. 

While growth in the medical technology industry has slowed due to recession and other factors, the significant drop in the rate of growth in the medical technology industry is most concerning. 

St. Jude Medical wins pre-market approval for two of its next-generation cardiac ablation systems. 

A team from MIT has designed a new biological dressing which has the potential to achieve almost an instant halt to bleeding, and can prove beneficial in reducing military and civil casualties.

Company celebrates "75 Years of Innovation" this year; reveals series of new products and services at the Orthopaedic Surgeons annual meeting this week. 

Device makers agree to double the fees they pay to FDA, to $595 million, in turn for faster, more predictable review process. 

Bain Capital describes troubled Physio-Control business as a market leader at the forefront of emergency response technology.

Following the health scare involving substandard breast implants, French authorities are asking for ‘radically redrafting’ EU law relating to medical devices. 

The CDRH reports a 44 percent increase in complaints compared with 2010, and lists other contacts that the agency had with the public last year.

Russian authorities are expected to implement new medical device regulations concerning authorized representation, vigilance, country-of-origin approval and other issues within the next several weeks.

The device industry surpasses, for the first time, the pharma industry in attracting VC funds.

Emerging markets is necessary like 401(k) says one leader, while another cautions that smaller companies need to stay closer to home and leave such countries to those with resources to play the long game. 

FDA has sent a letter warning J&J /DePuy that several of their hip, knee and joint replacement devices were "improperly marketed." 

Agency announces working together with Biocom in an effort to speed up review process for devices; CDRH chief also calls for more collaboration in medical devices industry. 

The U.S. Food and Drug Administration has missed a legal deadline to submit a proposal for Congressional approval over the cost of speeding up product reviews starting this year.